Autologous Stem Cell Therapy Achieves Massive Improvement in Pulmonary Disease

The Lung Institute is moving patients with pulmonary lung disease into the next generation with the advance of stem cell regenerative medicine.

The Lung Institute is improving the breathing function of thousands of people suffering from Chronic Obstructive Pulmonary Disease, known as COPD, Emphysema, Chronic Bronchitis, Pulmonary Fibrosis and Interstitial Lung Disease. Until recently, these diseases offered care and medicines which eased symptoms, and invasive surgery that offered results but was dangerous, and offered limited results. The solution to many of the symptoms and improved pulmonary health is stem cell therapy.

As explained on, stem cell therapy is the use of autologous stem cells. Autologous stem cells are the removal of blood from a patient. The autologous, hematopoietic stem cells are harvested, separated and immediately intravenously returned to the patient through an IV. This process repeated for a couple of days. When the stem cells re-enter the patient’s system they begin to reproduce new healthy cells in the heart, which are then released into the lungs where they continue to reproduce healthy oxygenized red blood cells and are transported into the bloodstream through the body. The patient is then monitored as an outpatient for improvement and continued reproduction of healthy cells.

This procedure isn’t for every patient and each patient is tested and approved for this treatment. Doctors would not administer this procedure without a patient health review and assurance that this method would only improve the patient’s condition and not cause additional stress as a result.

The Lung Institute began this process in 2013 and has performed this procedure on more than 3000 patients since they began. The results have been exceptional with a positive improvement rate of over 70% in patients with pulmonary disease.

The stem cell therapy is performed as an outpatient procedure and takes approximately three visits as a minimally invasive therapy. The future of regenerative medicine is looking encouraging and COPD and other pulmonary diseases may take a backseat as this treatment progresses.

It is important to realize that not all patients are participants for stem cell therapy, but a free consultation is easily scheduled by calling (800) 729-3065 and speak to one of the institutes patient care coordinators. You ca also contact us via Facebook. Or visit us at